These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 8822086)
1. The possible roles of hyperlipidemia and mononuclear cells in glomeruli in puromycin aminonucleoside nephrosis in rats. Hattori T; Nagamatsu T; Ito M; Suzuki Y Jpn J Pharmacol; 1996 Jan; 70(1):25-33. PubMed ID: 8822086 [TBL] [Abstract][Full Text] [Related]
2. Effect of a low-protein diet on expression of non-muscle type myosin heavy-chain isoforms in glomeruli of rats with puromycin aminonucleoside nephrosis. Koide H; Nakamura T; Kimura K; Ebihara I; Nagai R; Tomino Y Nephrol Dial Transplant; 1996 Sep; 11(9):1769-74. PubMed ID: 8918620 [TBL] [Abstract][Full Text] [Related]
3. Impact of cyclosporin on podocyte ZO-1 expression in puromycin aminonucleoside nephrosis rats. Kim BS; Park HC; Kang SW; Choi KH; Ha SK; Han DS; Lee HY Yonsei Med J; 2005 Feb; 46(1):141-8. PubMed ID: 15744817 [TBL] [Abstract][Full Text] [Related]
4. Experimentally induced puromycine aminonucleoside nephrosis (PAN) in rats: evaluation of angiogenic protein platelet-derived endothelial cell growth factor (PD-ECGF) expression in glomeruli. Seckin I; Uzunalan M; Pekpak M; Kokturk S; Sonmez H; Oztürk Z; Demirci S; Yaprak E J Biomed Sci; 2012 Feb; 19(1):24. PubMed ID: 22335899 [TBL] [Abstract][Full Text] [Related]
5. Retinoids as a potential treatment for experimental puromycin-induced nephrosis. Moreno-Manzano V; Mampaso F; Sepúlveda-Muñoz JC; Alique M; Chen S; Ziyadeh FN; Iglesias-de la Cruz MC; Rodríguez J; Nieto E; Orellana JM; Reyes P; Arribas I; Xu Q; Kitamura M; Lucio Cazana FJ Br J Pharmacol; 2003 Jun; 139(4):823-31. PubMed ID: 12813006 [TBL] [Abstract][Full Text] [Related]
6. Alterations in the glomerulus in aminonucleoside nephrosis in analbuminemic rats. Abe H; Shibuya T; Odashima S; Arichi S; Nagase S Nephron; 1988; 50(4):351-5. PubMed ID: 3237275 [TBL] [Abstract][Full Text] [Related]
7. Effect of clofibrate on fatty acid metabolism in the kidney of puromycin-induced nephrotic rats. Muroya Y; Ito O Clin Exp Nephrol; 2016 Dec; 20(6):862-870. PubMed ID: 26949064 [TBL] [Abstract][Full Text] [Related]
8. Altered expression of NDST-1 messenger RNA in puromycin aminonucleoside nephrosis. Nakayama K; Natori Y; Sato T; Kimura T; Sugiura A; Sato H; Saito T; Ito S; Natori Y J Lab Clin Med; 2004 Feb; 143(2):106-14. PubMed ID: 14966466 [TBL] [Abstract][Full Text] [Related]
9. Studies on antinephritic effect of TJ-8014, syo-saiko-to-kyo-shyokyo-ka-ouren-bukuryou (5): Effects on puromycin aminonucleoside nephrosis and its mechanisms. Hattori T; Ito M; Suzuki Y Jpn J Pharmacol; 1991 Aug; 56(4):465-73. PubMed ID: 1744988 [TBL] [Abstract][Full Text] [Related]
10. Glomerular sclerosis in nephrotic rats. Comparison of the long-term effects of adriamycin and aminonucleoside. Grond J; Weening JJ; Elema JD Lab Invest; 1984 Sep; 51(3):277-85. PubMed ID: 6471809 [TBL] [Abstract][Full Text] [Related]
11. Glomerular expression of smooth-muscle myosin heavy-chain isoforms in aminonucleoside nephrosis in rats. Nakamura T; Kimura K; Ebihara I; Takahashi T; Tomino Y; Aikawa M; Yazaki Y; Nagai R; Koide H Clin Sci (Lond); 1995 Jul; 89(1):45-52. PubMed ID: 7671567 [TBL] [Abstract][Full Text] [Related]
12. Renoprotective effect of the L/N-type calcium channel antagonist cilnidipine on puromycin aminonucleoside-induced nephrosis in rats. Takashima K; Nishiyama C; Arisaka N; Takahashi T; Souma S; Tsuda M; Hayashi M; Kasahara H; Kodama H; Tamura T; Murakami M; Kuroda J; Sato F Arzneimittelforschung; 2009; 59(2):79-85. PubMed ID: 19338138 [TBL] [Abstract][Full Text] [Related]
13. Dynamics of renal histamine in normal rat kidney and in nephrosis induced by aminonucleoside of puromycin. Abboud HE; Ou SL; Velosa JA; Shah SV; Dousa TP J Clin Invest; 1982 Feb; 69(2):327-36. PubMed ID: 7056851 [TBL] [Abstract][Full Text] [Related]
14. Modulation of glomerular endothelin and endothelin receptor gene expression in aminonucleoside-induced nephrosis. Nakamura T; Ebihara I; Fukui M; Osada S; Tomino Y; Masaki T; Goto K; Furuichi Y; Koide H J Am Soc Nephrol; 1995 Feb; 5(8):1585-90. PubMed ID: 7756592 [TBL] [Abstract][Full Text] [Related]
15. Differences in puromycin aminonucleoside nephrosis in two rat strains. Grond J; Muller EW; van Goor H; Weening JJ; Elema JD Kidney Int; 1988 Feb; 33(2):524-9. PubMed ID: 3361753 [TBL] [Abstract][Full Text] [Related]
16. Glomerular tumor necrosis factor and interleukin 1 during acute aminonucleoside nephrosis. An immunohistochemical study. Diamond JR; Pesek I Lab Invest; 1991 Jan; 64(1):21-8. PubMed ID: 1990206 [TBL] [Abstract][Full Text] [Related]
17. Suppressed activities of cathepsins and metalloproteinases in the chronic model of puromycin aminonucleoside nephrosis. Huang S; Schaefer RM; Reisch S; Paczek L; Schaefer L; Teschner M; Sebekova K; Heidland A Kidney Blood Press Res; 1999; 22(3):121-7. PubMed ID: 10394110 [TBL] [Abstract][Full Text] [Related]
18. Mizoribine reduces urinary protein excretion in rats given puromycin aminonucleoside. Shibasaki T; Matsuda H; Gomi H; Usui M; Ishimoto F; Sakai O Am J Nephrol; 1996; 16(2):167-72. PubMed ID: 8919236 [TBL] [Abstract][Full Text] [Related]
19. Adrenomedullin ameliorates podocyte injury induced by puromycin aminonucleoside in vitro and in vivo through modulation of Rho GTPases. Dong N; Meng L; Xue R; Yu M; Zhao Z; Liu X Int Urol Nephrol; 2017 Aug; 49(8):1489-1506. PubMed ID: 28528353 [TBL] [Abstract][Full Text] [Related]